Skip to content

H.Res. 309 · 118th Congress (2023–2025)

Expressing the sense of the House of Representatives that the Food and Drug Administration has the authority to approve drugs for abortion care.

This resolution expresses the sense of the House of Representatives that the Food and Drug Administration (FDA) has the authority to review and approve drugs pursuant to its own expertise, and that recent court decisions blocking the FDA's approval of mifepristone (which is used in medication abortion) violate congressional intent with respect to the FDA's authority.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to committee

This bill’s path

This is H.Res. 309’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Kathy E. Manning (D-NC-6)
Cosponsors
48 cosponsors

33 original · 15 later

48 D

  1. Rep. Jake Auchincloss (D-MA-4)· Original · Apr 19, 2023
  2. Rep. Nikki Budzinski (D-IL-13)· Original · Apr 19, 2023
  3. Rep. Gerald E. Connolly (D-VA-11)· Original · Apr 19, 2023
  4. Rep. Judy Chu (D-CA-28)· Original · Apr 19, 2023
  5. Rep. Jasmine Crockett (D-TX-30)· Original · Apr 19, 2023
  6. Rep. Greg Casar (D-TX-35)· Original · Apr 19, 2023
  7. Rep. Yadira Caraveo (D-CO-8)· Original · Apr 19, 2023
  8. Rep. Christopher R. Deluzio (D-PA-17)· Original · Apr 19, 2023
  9. Rep. Veronica Escobar (D-TX-16)· Original · Apr 19, 2023
  10. Rep. Brian Higgins (D-NY-26)· Original · Apr 19, 2023
  11. Rep. Glenn Ivey (D-MD-4)· Original · Apr 19, 2023
  12. Rep. Rick Larsen (D-WA-2)· Original · Apr 19, 2023
  13. Rep. Greg Landsman (D-OH-1)· Original · Apr 19, 2023
  14. Rep. Gwen Moore (D-WI-4)· Original · Apr 19, 2023
  15. Rep. Grace Meng (D-NY-6)· Original · Apr 19, 2023
  16. Rep. Frank J. Mrvan (D-IN-1)· Original · Apr 19, 2023
  17. Del. Eleanor Holmes Norton (D-DC)· Original · Apr 19, 2023
  18. Rep. Wiley Nickel (D-NC-13)· Original · Apr 19, 2023
  19. Rep. Jimmy Panetta (D-CA-19)· Original · Apr 19, 2023
  20. Rep. Chris Pappas (D-NH-1)· Original · Apr 19, 2023
  21. Rep. Ayanna Pressley (D-MA-7)· Original · Apr 19, 2023
  22. Rep. Katie Porter (D-CA-47)· Original · Apr 19, 2023
  23. Rep. Brittany Pettersen (D-CO-7)· Original · Apr 19, 2023
  24. Rep. Janice D. Schakowsky (D-IL-9)· Original · Apr 19, 2023
  25. Rep. Bradley Scott Schneider (D-IL-10)· Original · Apr 19, 2023
  26. Rep. Mary Gay Scanlon (D-PA-5)· Original · Apr 19, 2023
  27. Rep. Emilia Strong Sykes (D-OH-13)· Original · Apr 19, 2023
  28. Rep. Andrea Salinas (D-OR-6)· Original · Apr 19, 2023
  29. Rep. Dina Titus (D-NV-1)· Original · Apr 19, 2023
  30. Rep. Paul Tonko (D-NY-20)· Original · Apr 19, 2023
  31. Rep. Jill N. Tokuda (D-HI-2)· Original · Apr 19, 2023
  32. Rep. Nikema Williams (D-GA-5)· Original · Apr 19, 2023
  33. Rep. Susan Wild (D-PA-7)· Original · Apr 19, 2023
  34. Rep. Cori Bush (D-MO-1)· Later · Apr 24, 2023
  35. Rep. Julia Brownley (D-CA-26)· Later · Apr 24, 2023
  36. Rep. Sharice Davids (D-KS-3)· Later · Apr 24, 2023
  37. Rep. Josh Gottheimer (D-NJ-5)· Later · Apr 24, 2023
  38. Rep. Sydney Kamlager-Dove (D-CA-37)· Later · Apr 24, 2023
  39. Rep. Mike Levin (D-CA-49)· Later · Apr 24, 2023
  40. Rep. Betty McCollum (D-MN-4)· Later · Apr 24, 2023
  41. Rep. Haley M. Stevens (D-MI-11)· Later · Apr 24, 2023
  42. Rep. Debbie Wasserman Schultz (D-FL-25)· Later · Apr 24, 2023
  43. Rep. Becca Balint (D-VT)· Later · Apr 27, 2023
  44. Rep. Deborah K. Ross (D-NC-2)· Later · Apr 27, 2023
  45. Rep. Jamie Raskin (D-MD-8)· Later · Apr 27, 2023
  46. Rep. Troy A. Carter (D-LA-2)· Later · May 10, 2023
  47. Rep. Robin L. Kelly (D-IL-2)· Later · May 10, 2023
  48. Rep. Mikie Sherrill (D-NJ-11)· Later · May 10, 2023
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    Sources
  3. Expired

    Introduced → Referred to House Energy and Commerce → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Apr 19, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (1)
  1. Expressing the sense of the House of Representatives that the Food and Drug Administration has the authority to approve drugs for abortion care.

    Display title, Official title · Introduced in House